Long Q - Search Results

1

Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.

Long Q, Lin TY, Huang Y, Li X, Ma AH, Zhang H, Carney R, Airhart S, Lam KS, deVere White RW, Pan CX, Li Y. Long Q, et al. Nanomedicine. 2018 Apr;14(3):789-799. doi: 10.1016/j.nano.2017.12.014. Epub 2018 Jan 6. Nanomedicine. 2018. PMID: 29317342 Free PMC article.

2

HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy.

Lin TY, Guo W, Long Q, Ma A, Liu Q, Zhang H, Huang Y, Chandrasekaran S, Pan C, Lam KS, Li Y. Lin TY, et al. Among authors: long q. Theranostics. 2016 Jun 7;6(9):1324-35. doi: 10.7150/thno.14882. eCollection 2016. Theranostics. 2016. PMID: 27375782 Free PMC article.

3

Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia.

Lin TY, Zhu Y, Li Y, Zhang H, Ma AH, Long Q, Keck J, Lam KS, Pan CX, Jonas BA. Lin TY, et al. Among authors: long q. Nanomedicine. 2019 Aug;20:102004. doi: 10.1016/j.nano.2019.04.007. Epub 2019 May 2. Nanomedicine. 2019. PMID: 31055076 Free PMC article.

4

Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.

Long Q, Ma AH, Zhang H, Cao Z, Xia R, Lin TY, Sonpavde GP, de Vere White R, Guo J, Pan CX. Long Q, et al. Cancer Immunol Immunother. 2020 Nov;69(11):2305-2317. doi: 10.1007/s00262-020-02609-5. Epub 2020 Jun 6. Cancer Immunol Immunother. 2020. PMID: 32506263 Free PMC article.

5

Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.

Xiong Y, Liu L, Wang J, Xi W, Xia Y, Bai Q, Qu Y, Long Q, Xu J, Guo J. Xiong Y, et al. Among authors: long q. Oncotarget. 2017 Apr 11;8(15):25650-25659. doi: 10.18632/oncotarget.12827. Oncotarget. 2017. PMID: 27783999 Free PMC article.

6

Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression.

Xu Q, Long Q, Zhu D, Fu D, Zhang B, Han L, Qian M, Guo J, Xu J, Cao L, Chin YE, Coppé JP, Lam EW, Campisi J, Sun Y. Xu Q, et al. Among authors: long q. Aging Cell. 2019 Dec;18(6):e13027. doi: 10.1111/acel.13027. Epub 2019 Sep 7. Aging Cell. 2019. PMID: 31493351 Free PMC article.

7

High peritumoral Bmi-1 expression is an independent prognosticator of poor prognosis in renal cell carcinoma.

Long Q, Liu L, Xia Y, Bai Q, Wang J, Xu J, Guo J. Long Q, et al. Tumour Biol. 2015 Sep;36(10):8007-14. doi: 10.1007/s13277-015-3525-9. Epub 2015 May 14. Tumour Biol. 2015. PMID: 25967455

8

Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma.

Xia Y, Liu L, Bai Q, Wang J, Xi W, Qu Y, Xiong Y, Long Q, Xu J, Guo J. Xia Y, et al. Among authors: long q. Sci Rep. 2016 Sep 7;6:32657. doi: 10.1038/srep32657. Sci Rep. 2016. PMID: 27600310 Free PMC article.

9

Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.

Bai Q, Liu L, Long Q, Xia Y, Wang J, Xu J, Guo J. Bai Q, et al. Among authors: long q. Int J Clin Exp Pathol. 2015 Sep 1;8(9):11005-14. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26617818 Free PMC article.

10

Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma.

Qu Y, Liu L, Wang J, Xi W, Xia Y, Bai Q, Xiong Y, Long Q, Xu J, Guo J. Qu Y, et al. Among authors: long q. Oncotarget. 2016 Dec 20;7(51):84775-84784. doi: 10.18632/oncotarget.12476. Oncotarget. 2016. PMID: 27713173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,614 results

Search Page

Filters